Company / SG&A per Share
enGene Holdings Inc. SG&A per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.56
FY2025
5-year range
$0.56 / $13.86
FY2022-FY2025
Trend
-11.6%
vs FY2024
Sector context
#157 of 206
Health Care
What the data says
enGene Holdings Inc.'s sg&a per share of $0.56 is lower than 76% of companies in the Health Care sector (FY2025). Improved from $13.86 to $0.56 over the past 2 years.
Based on SEC 10-K filings.
0.56 in FY2025 with a 3-year CAGR of -54.7%.
Improved from $13.86 to $0.56 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -54.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 24% in Health CareTop 24% of 206This company $0.56 Sector average $44.68
▼
-98.7% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share decreased 11.6% year-over-year.
- Ranks #157 out of 206 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 0.13 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.56 | -11.6% |
| FY2024 | $0.63 | -95.4% |
| FY2023 | $13.86 | +129.4% |
| FY2022 | $6.04 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026